Development of a new drug to treat advanced state prostate cancer

Srathclyde Institute for Pharmacy and Biological Sciences, GlasgowProfessor Simon Mackay£249,2892013 - 2016

The project in a nutshell

Refining compounds for use as a drug treatment that stop a protein that appears to be key to the development of prostate cancer.

Why we funded it

This treatment could offer a way of increasing the life expectancy of men with advanced prostate cancer.

For more detailed information on this project, please look at the lay summary